A trial fibrillation (AF) is increasingly recognized as an important cause of ischemic stroke whose importance is magnified because of the remarkable efficacy of oral anticoagulants for stroke prevention.
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in the past decade consistently report higher frequencies, [4] [5] [6] [7] possibly because of increased surveillance and inclusion of older stroke cohorts. The frequency and features of AF-associated stroke across global regions have not been previously studied, as data have primarily been collected from Europe and North America. Here, we report the prevalence of AF-associated stroke from 19 stroke centers in 19 countries and compare features with ischemic stroke not associated with recognized AF.
Methods
The design and initial findings from the ESUS (Embolic Stroke of Undetermined Source) Global Registry have been previously published. 8 Consecutive patients with recent ischemic stroke were obtained from 19 stroke centers in 19 different countries, targeting a review of 100 patients with acute ischemic stroke at each site. Sites were instructed to retrospectively identify consecutive inpatients evaluated for recent stroke in 2013 to 2014 from hospital discharge diagnosis codes or from databases associated with acute stroke units. The study complied with local institutional research board regulations; informed consent was not required at any site for this anonymized data collection. Data were entered into a central database at the Population Health Research Institute via on-line data entry or via an automated fax-based data entry system. Missing data were queried, and final data were exported to STATA 13.0 for statistical analysis.
AF-associated stroke was defined as an ischemic stroke associated with any history of AF, AF on any electrocardiography done for the index stroke, or AF detected on cardiac rhythm monitoring (including inpatient telemetry or ambulatory monitoring with automated rhythm detection) done after stroke. Given the nature of the global registry, data were not collected about the duration of paroxysmal AF or about antithrombotic therapy before or after stroke.
Data were analyzed according to 4 global regions: Europe (9 sites), North America (2 sites), Latin America (3 sites), and East Asia/Pacific (5 sites). Sites were also grouped into 4 World Bank income groups (low, lower middle, upper middle, and high; World Bank Group; http://data.worldbank.org/about/country-classifications).
Categorical data were summarized as counts and percentages, and comparisons were made using χ 2 test. Continuous data were summarized using mean and SD, and comparisons were made using t test or Wilcoxon signed-rank test, as appropriate. Correlation coefficient was used to determine the association between the mean age of stroke cohort and the frequency of AF among centers. All analyses were performed using SAS software, version 9.2 (SAS Institute Inc, Cary, NC). A 2-sided P value of <0.05 was considered statistically significant.
Results

Frequency of AF-Associated Stroke by Site, Global Region, and Age
Of 2144 patients with recent ischemic stroke (mean age, 67 years; SD, 15.39 years) collected from 19 stroke research centers in 19 countries, the frequency of AF-associated stroke was 28% (95% confidence interval [CI], 25.6-29.5), ranging from 11% in Manila, Philippines, to 45% in Galway, Ireland ( Table 1 ). The prevalence of AF-associated stroke was highest at sites in Europe (33%) and North America (35%) and lowest at Latin American sites (17%; Table 2 ). When comparing the 14 sites from high-income countries (n=1516) and 5 sites from upper middle-income countries (n=628), the prevalence of AF-associated stroke was higher at sites in highincome countries (32.5%; 95% CI, 30.1-34.8) compared with upper middle-income countries (15.6%; 95% CI, 12.8-18.4; Figure 1 ).
Patients with AF-associated stroke were, on average, substantially older (mean age, 75 years; SD, 11.45 years) than patients with ischemic stroke unassociated with AF (mean age, 64 years; SD, 15.51 years; P<0.001), and this decade difference was consistent across global regions (Table 2 ). There was a strong and significant correlation between the mean age of the stroke cohort and the frequency of AF among sites ( Figure 2 ).
Identification of AF Among Patients With Ischemic Stroke
Of the 590 ischemic strokes associated with AF, 332 (56%; 95% CI, 52.1-60.3) had a history of AF before the index stroke, and an additional 207 (35%; 95% CI, 31.2-39.1) without a history of AF had AF diagnosed by electrocardiography done for evaluation of the index stroke, and 51 (8%; 95% CI, 6.4-10.9) had AF diagnosed by prolonged cardiac rhythm monitoring (Table 3 ). In our study cohort of 2144 patients with ischemic stroke, 1108 (69%) patients (who did not have a diagnosis of AF before the index stroke or who were not diagnosed with AF on the basis of a 12-lead ECG) underwent ≥24-hour cardiac rhythm monitoring, and the yield of cardiac rhythm monitoring to detect AF was 4.6%. 
Clinical Features of Ischemic Stroke Patients With and Without Associated AF
In patients with AF-associated stroke, only 6% presented with a lacunar stroke (<1.5 cm in largest diameter subcortical or pontine infarct) as their index stroke; this was significantly lower than the patients with non-AF-associated stroke where 20% presented with lacunar stroke as their index stroke. Nine percent of the patients with AF had ≥50% stenosis in the ipisilateral cervical carotid artery detected by ultrasound Doppler, magnetic resonance angiography, or computed tomographic angiography. In the patients with non-AF ischemic stroke, 15% had ≥50% ipsilateral carotid stenosis. Thirty-day mortality among patients with AF was significantly higher (10%; 95% CI, 7.6-12.6) compared with patients with non-AF ischemic stroke (4%; 95% CI, 3.3-5.4; P<0.0001; Table 4 ).
Relationship Between the Frequency of AF-Associated Stroke and the Mean Age of the Ischemic Stroke Cohort
Overall, AF was more common in those >75 years old (44%) versus those <75 years old (18%; P=0.0001), with almost half of the ischemic strokes in women >75 years old associated with AF (46%). There was a strong positive correlation between the mean age of patients with stroke and the frequency of AF among sites (r=0.76; P=0.0002).
Discussion
This global registry project demonstrates that AF-associated ischemic stroke is common: 28% of ischemic strokes at the 19 international sites and one third of strokes at sites in Europe and North America. Our findings show that patients with AF were almost a decade older than patients without AF across global regions. Differences in prevalence between sites and regions are largely because of the variation in mean ages of the stroke populations. There was a strong and significant correlation between the mean age of the stroke cohort and the frequency of AF among sites. Compared with other regions, Latin America had the lowest frequency of AF-related stroke; this likely reflects the lower average age of the stroke population in Latin America, which was on average a decade lower than stroke populations from other regions. The attributed risk of AF for ischemic stroke in a given population is expected to be influenced by the life expectancy of the population, 9 and this might partly explain regional variations in frequency of AF between high-income and upper middle-income countries in our study. This regional variability could also be partly explained by the variability of access to diagnostic tests in each center; at least hypothetically, we can assume that access to prolonged monitoring for AF detection to be easier in highincome regions, compared with upper middle-income regions.
AF was identified in 28% (95% CI, 25.6-29.5) of consecutive patients with ischemic stroke, a higher fraction than in hospitalized patients with ischemic stroke in past decades (typically between 15% and 20%) 3 probably because of increasing vigilance in detecting AF, the increasing prevalence of AF in the elderly, 9 and inclusion of more elderly stroke cohorts. 
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Recent studies published since the registry demonstrate that prolonged (>1 month) cardiac rhythm monitoring identifies additional patients with cryptogenic stroke who have episodes of paroxysmal AF, 10, 11 which are often brief and of uncertain pathogenic relevance. 12 The increase in the frequency of AF-associated stroke relative to other ischemic strokes has occurred despite more widespread use of oral anticoagulation in patients with AF. 9 More than half of AF-related strokes occurred in patients with a known history of AF. Although no data on antithrombotic or anticoagulant therapy were available, this finding stresses the importance of optimizing stroke prevention in patients with known AF.
In our stroke cohort, 6% of the patients with AF had lacunar stroke as their index stroke compared with 20% of patients without AF, and the differences in frequency were consistent across global regions and consistent with previous studies, suggesting that AF-related strokes are more frequently larger. It must be acknowledged that accurate subtyping of stroke may not be possible in all cases even with advanced neuroimaging and vascular imaging techniques and that some lacunar strokes could have cardioembolic or atheroembolic sources. However, previously published data on anticoagulation treatment in patients with AF who present with lacunar stroke show no benefit of anticoagulation compared with antiplatelet treatment in reducing the risk of recurrent stroke. 13, 14 With this knowledge, it would have been interesting to explore whether stroke subtype influenced physician decision on choosing an antithrombotic for secondary stroke prevention. Unfortunately, we did not collect data on the discharge antithrombotic in our study cohort.
In our study cohort, the 30-day mortality was significantly higher for patients with AF when compared with patients without AF across global regions. Our findings are consistent and in accordance with the larger randomized trials. Our findings show a significant correlation between the mean age of patients with stroke and the frequency of AF, which is statistically significant and in keeping with several recent observational data. 9, 15, 16 Limitations of this study include participation by a limited number of selected, high-volume stroke centers, and therefore, the results may not be generalizable to all patients with ischemic stroke. There were no sites included from low-and middle-income countries, including sub-Saharan countries where the global burden of stroke is known to be the greatest. 17 A single site in each country may not accurately reflect the frequency of AF for the country. This hospital/stroke unitbased registry did not capture patients with stroke who were not hospitalized for stroke. Because of the primary reason of the registry, several interesting stroke-related data, such as therapy, outcome, and cardiovascular risk factors, were only collected in the subgroup of ESUS patients and thus not available for patients with AF-related stroke. However, the study sites represented many global regions allowing unique comparison of AF-associated stroke around the world, and the frequency of AF in our study (28%) is broadly in line with figures reported in recent studies, supporting the external validity of our findings.
In summary, this study provides a unique perspective on the global burden of AF-associated stroke. AF-associated stroke comprises an important (28%; 95% CI, 25.6-29.5) subset of patients with ischemic stroke around the world and is the most frequent cause of ischemic stroke in elderly women. These strokes are potentially preventable.
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